Semaglutide brought 40.4% of children below the obesity BMI threshold, according to top-line results from the phase 3 STEP Young clinical trial.
|Articles|May 11, 2023
Daily Dose: Testicular Volume in Boys with Obesity
Author(s)Sydney Jennings
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On May 10, 2023, we reported on a study published in the European Journal of Endocrinology that examined the impact of obesity, hyperinsulinemia, and insulin resistance on testicular volume (TV) among boys aged 2-18 years.
The study
Researchers conducted a retrospective, cross-sectional study to evaluate the impact of overweight, obesity, and related comorbidities, eg, hyperinsulinemia, and insulin resistance, on TV in prepubertal (aged <9 years), peripubertal (aged 9-14 years), and post-pubertal (aged 14-16 years) periods. A total of 268 boys were included in the study, of whom 206 were overweight or obese and 62 were normal weight.
The findings
Results showed that boys with normal weight had a significantly higher TV compared to those who were overweight or obese in peripubertal age. No difference was found in the other age ranges when data were grouped according to body mass index.
Participants with normal insulin levels had significantly higher TV compared to those with hyperinsulinemia in pre- and post-pubertal age. Moreover, peripubertal boys with hyperinsulinemia had significantly higher TV compared to those with normal insulin levels.
Postpubertal participants with insulin resistance had lower TV and peripubertal boys had higher TV compared to those without insulin resistance. Investigators did not note a difference in prepuberty.
A note from authors
"Since a lower TV is predictive of worse sperm production, these results help to understand the reason for the high prevalence of testicular hypotrophy in young men. We speculate that more careful control of body weight in this time window could represent a prevention strategy to pursue the maintenance of testicular function later in life. If further studies will confirm our findings, there will be room for primary prevention of male infertility in pediatric clinics (pediatric andrology). Indeed, an accurate assessment of TV at each visit and the construction of TV growth curves would help identify early deviations in TV growth in children and adolescents."
Click here for more details.
Advertisement
Related to this article
US clinicians increasingly prescribe GLP-1 drugs to young children with obesity, although overall use remains limited and access disparities persist.
EASD 2026: Oral semaglutide users lost 4.1% of body weight 3 months after switching from injections in an observational study without a comparator group.
EASD 2026: The combination of semaglutide/cagrilintide altered food-cue responses and showed a 22.4% estimated weight difference vs placebo; separate data found less organ fat in type 2 diabetes.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
A new scientific statement calls for a shift in obesity management and treatment to focus on overall health improvements rather than just weight loss alone.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Advertisement
Advertisement
Trending on Patient Care Online
1
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
2
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
3
Why Real-World Evidence Matters for Nonhormonal Menopause VMS Therapy
4
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
5